Articles By Anuja Singh
Did Immunology Approvals in 2025 Redefine Autoimmune Care—and Set the Stage for a New…
Global – December 2025 — The immunology sector entered a decisive transformation in 2025, marked by major regulatory…
ByDid Oncology Approvals in 2025 Reshape the Competitive Landscape—and Set the Stage for a…
Global – December 2025 — The oncology sector reached a strategic inflection point in 2025, as a surge…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical Secures Manufacturing Approval for Class II…
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced that its subsidiary,…
Phase 3 Clinical Trials of Setrusumab in Osteogenesis Imperfecta Fail to Meet Primary Endpoints
London & Novato, Calif. — December 2025 Mereo BioPharma Group plc (NASDAQ: MREO) and Ultragenyx Pharmaceutical Inc. (NASDAQ:…
The Best Feeling Is When Our Drugs Succeed”: Dame Emma Walmsley Reflects on GSK’s…
London | December 2025 GlaxoSmithKline (GSK) today highlighted a defining reflection from its outgoing Chief Executive Officer, Dame…
Neuroscience Biopharma in Transformation: Pipeline and Commercial Dynamics Reshape the Industry
Washington, D.C. — The neuroscience segment is undergoing a significant strategic transformation, driven by breakthroughs in neurodegenerative, psychiatric,…
Did Immunology Approvals in 2025 Redefine Autoimmune Care—and Set the Stage for a New…
Global – December 2025 — The immunology sector entered a decisive transformation in 2025, marked by major regulatory…
Did Oncology Approvals in 2025 Reshape the Competitive Landscape—and Set the Stage for a…
Global – December 2025 — The oncology sector reached a strategic inflection point in 2025, as a surge…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical Secures Manufacturing Approval for Class II…
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced that its subsidiary,…
Phase 3 Clinical Trials of Setrusumab in Osteogenesis Imperfecta Fail to Meet Primary Endpoints
London & Novato, Calif. — December 2025 Mereo BioPharma Group plc (NASDAQ: MREO) and Ultragenyx Pharmaceutical Inc. (NASDAQ:…
The Best Feeling Is When Our Drugs Succeed”: Dame Emma Walmsley Reflects on GSK’s…
London | December 2025 GlaxoSmithKline (GSK) today highlighted a defining reflection from its outgoing Chief Executive Officer, Dame…
Neuroscience Biopharma in Transformation: Pipeline and Commercial Dynamics Reshape the Industry
Washington, D.C. — The neuroscience segment is undergoing a significant strategic transformation, driven by breakthroughs in neurodegenerative, psychiatric,…